Occidental Asset Management, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Occidental Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.5 - $1.06 $10,000 - $21,200	-20,000 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$0.92 - $1.22 $18,400 - $24,400	20,000 New	20,000 $20,000
Q3 2021 Nov 03, 2021	SELL	$0.67 - $1.51 $8,040 - $18,120	-12,000 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$0.75 - $1.1 $9,000 - $13,200	12,000 New	12,000 $9,000

25.8M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $34.7M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Occidental Asset Management, LLC with notifications on news.